Showing results (231-240 of 311) with videos related to

Sort By:
Pageof 32
Annals of Physical and Rehabilitation Medicine|January 16, 2025
Comparative effectiveness of various exercise interventions on central sensitisation indices: A systematic review and network meta-analysisAya Abd Elkhabir Ibrahim, Daniel F McWilliams, Stephanie L Smith, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 1994
Relationship between radiobiological hypoxia in tumors and electrode measurements of tumor oxygenationM R Horsman, A A Khalil, D W Siemann, et al.
Infection and Immunity|November 24, 1999
Targeting improves the efficacy of a DNA vaccine against Corynebacterium pseudotuberculosis in sheepP J Chaplin, R De Rose, J S Boyle, et al.
Radiation Research. Supplement|January 1, 1985
In vitro and in vivo studies of the TRIUMF pion therapy beamL D Skarsgard, B G Douglas, J Denekamp, et al.
BMC Geriatrics|February 15, 2024
The association of painful and non-painful morbidities with frailty: a cross sectional analysis of a cohort of community dwelling older people in EnglandW J Chaplin, H R Lewis, S M Shahtaheri, et al.
Cancer Research|August 28, 2001
Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: intravital microscopy and measurement of vascular permeabilityG M Tozer, V E Prise, J Wilson, et al.
International Journal of Environmental Research and Public Health|November 24, 2023
Alcohol Prevention in Urgent and Emergency Care (APUEC): Development and Evaluation of Workforce Digital Training on Screening, Brief Intervention, and Referral for TreatmentHolly Blake, Emma J Adams, Wendy J Chaplin, et al.
Veterinary Research|November 10, 2016
L-BSE experimentally transmitted to sheep presents as a unique disease phenotypeMarion M Simmons, Melanie J Chaplin, Timm Konold, et al.
British Journal of Cancer|December 1, 1995
Cytotoxic effect of RB 6145 in human tumour cell lines: dependence on hypoxia, extra- and intracellular pH and drug uptakeL D Skarsgard, D K Acheson, A Vinczan, et al.
Anticancer Research|June 25, 2003
Oxi4503, a novel vascular targeting agent: effects on blood flow and antitumor activity in comparison to combretastatin A-4 phosphateJianyi Hua, Yezhou Sheng, Kevin G Pinney, et al.
Pageof 32